FEMY
NASDAQ
$3.27
Femasys Inc (FEMY)
Femasys Inc. is a pioneering medical technology company focused on revolutionizing women's healthcare with its proprietary, non-surgical solutions for diagnosing and treating gynecological conditions, including uterine fibroids and contraception. By addressing significant unmet needs in women's health, Femasys is positioned to benefit from the growing demand for minimally invasive treatments, which enhance patient outcomes and improve healthcare efficiency. The company's innovative approach aims to set new standards of care, reinforcing its commitment to transforming the landscape of women's health and solidifying its role as a key player in this vital and expanding market.
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Strong Buy
Target: $63.33 (+1836.70%)
Market Cap
$11M
Beta (5Y)
1.11
Price Chart
Valuation
Market Cap$11M
P/S4.54
P/B1.50
Profitability
Total Revenue (TTM)$2.38M
Gross Profit (TTM)$1.46M
EBITDA-$16M
Operating Margin-994%
EPS-$5.63
Growth & Risk
Beta (5Y)1.11
Sharpe Ratio-0.72